KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Capital Expenditures (2016 - 2026)

West Pharmaceutical Services has reported Capital Expenditures over the past 18 years, most recently at $26.1 million for Q1 2026.

  • Quarterly Capital Expenditures fell 63.39% to $26.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $240.7 million through Mar 2026, up 206.23% year-over-year, with the annual reading at $285.9 million for FY2025, 439.43% up from the prior year.
  • Capital Expenditures was $26.1 million for Q1 2026 at West Pharmaceutical Services, down from $76.1 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $230.5 million in Q3 2024 and troughed at -$219.1 million in Q4 2024.
  • The 5-year median for Capital Expenditures is $66.1 million (2022), against an average of $44.7 million.
  • Biggest five-year swings in Capital Expenditures: crashed 301.56% in 2024 and later surged 1934.15% in 2025.
  • Tracing WST's Capital Expenditures over 5 years: stood at -$156.5 million in 2022, then surged by 169.46% to $108.7 million in 2023, then tumbled by 301.56% to -$219.1 million in 2024, then soared by 134.73% to $76.1 million in 2025, then tumbled by 65.7% to $26.1 million in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $26.1 million, $76.1 million, and $63.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.